Cancer Advances

May 12, 2022

Discoveries in CAEL-101 Trial for Patients with AL Amyloidosis

Jason Valent, MD, Director of the Multiple Myeloma Program and Co-Director of the Amyloidosis Program at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss the developments of the CAEL-101 trial for patients with AL amyloidosis. Listen as Dr. Valent talks about the discoveries and changes in treatment in each phase of the trial.

May 5, 2022

Looking Out for Rare Cancer: Uveal Melanoma

Arun Singh, MD, Director of Ophthalmic Oncology at Cleveland Clinic Cole Eye Institute, joins the Cancer Advances podcast to discuss uveal melanoma. Listen as Dr. Singh explains the symptoms to look out for, treatment, and new therapies in development for this rare eye cancer.

April 28, 2022

Transperineal Biopsy and Advancements in Screening for Prostate Cancer

Urologic oncologist in the Glickman Urological and Kidney Institute, Zeyad Schwen, MD joins the Cancer Advances podcast to discuss transperineal biopsy and advances in screening for prostate cancer. Listen as Dr. Schwen explains the benefits of the transperineal prostate biopsy technique and why with the use of better imaging, as well as reduced risks of infection, this technique is coming to the forefront.

April 21, 2022

Esophageal Cancer Program

Suneel Kamath, MD, hematologist/medical oncologist and Siva Raja, MD, PhD, Surgical Director of the Center for Esophageal Diseases joins the Cancer Advances podcast to discuss the Esophageal Cancer Program. Listen as Dr. Kamath and Dr. Raja discuss this multidisciplinary program and the significant advancements that have been made over the last several years including less invasive therapies to treat esophageal cancer.